Balasabas, Crislie T.
HRN: 20-76-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2024
CEFUROXIME 1.5GM (VIAL)
11/03/2024
11/04/2024
IV
1.5g
1hr PTOR
Parotid Gland Mass Right
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes